Peps
What is MGF?
MGF can refer to an IGF-1 splice-product context or a synthetic terminal E-peptide. A primary replication study found no apparent effect of the tested MGF peptides on muscle-cell proliferation or differentiation.
Biological role or research focus
Muscle-cell signaling and replication findings.
Negative replication challenges broad muscle-regeneration claims. It does not prove that every splice product or future preparation lacks activity in all settings.
Names you may encounter
Mechano-growth factor · MGF E-peptide
Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.
- Class / identity
- IGF-1 splice-product / E-peptide research label
- Research focus
- Muscle-cell signaling and replication findings
- Featured evidence
- Cell study with negative replication findings
- Source check
- October 4, 2026
Biology & proposed mechanism
The study separated a synthetic terminal fragment from mature IGF-1 and full-length IGF-1Eb. A response to the full protein cannot be attributed automatically to the isolated fragment.
Research context & identity
This profile covers unpegylated MGF peptide research. PEG-MGF is a different conjugate whose sequence, polymer, and attachment must be specified.
What does the evidence show?
Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.
Cell study with negative replication findings · 2014
MGF peptide replication in muscle cells
What did this publication test, and what did it find?
- Population / model
- C2C12 cells, primary human muscle myoblasts, and primary mouse muscle stem cells.
- Study design
- Laboratory attempts to reproduce proposed proliferation, differentiation, and signaling effects using MGF peptides and IGF-1-related controls.
- Main finding
- MGF did not increase proliferation or inhibit differentiation in the tested systems. IGF-1 and full-length IGF-1Eb produced proliferative responses; tested MGF peptides also failed to demonstrate the proposed signaling response.
- Limits & context
- Negative replication challenges broad muscle-regeneration claims. It does not prove that every splice product or future preparation lacks activity in all settings.
Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.
Further reading · 4 additional publication links
Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.
Mechano-growth factor reduces loss of cardiac function in acute myocardial infarction. ↗
Heart, lung & circulation · 2008 Feb · Comparative Study, Journal Article
African swine fever virus MGF_110-3L and MGF_110-4L signal TLR2-mediated lethal inflammation. ↗
Protein & cell · 2026 Jul 14 · Journal Article
Growth factors and muscle ageing. ↗
Experimental gerontology · 2004 Oct · Journal Article, Research Support, Non-U.S. Gov't, Review
Mangiferin: A natural neuroprotective polyphenol with anti-inflammatory and anti-oxidant properties for depression. ↗
Progress in neuro-psychopharmacology & biological psychiatry · 2025 Jun 20 · Journal Article, Review, Research Support, Non-U.S. Gov't
New editorial updates
New source discoveries
Links appear automatically. Unreviewed discoveries are not verified medical findings.
Safety & precautions
Safety & what remains unknown
Cell experiments do not establish systemic safety or a useful human muscle-recovery intervention.
Evidence boundaries
Negative replication challenges broad muscle-regeneration claims. It does not prove that every splice product or future preparation lacks activity in all settings.
This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.
What are people discussing?
No editorial transcript note has been reviewed for this profile yet. Below are the matching video records available for exploration; title and caption matches are not verified claims.
Watch the source discussions
2 matching video records · 0 with captions indexed.
Across the full library, 30 caption files are indexed from 20,199 inventoried videos. Most transcripts remain unreviewed. Select a thumbnail or timestamp to watch inside PepsRadar. Thumbnail images load from YouTube.
Biohackingturkey
PEG-MGF Nedir? Kas Gelişiminde Gerçekten İşe Yarıyor mu? ↗
Title match · Captions not indexed
Trevor Kruder
MGF is the Repair Guy in the IGF Family ↗
Title match · Captions not indexed
Sources & supplier listings
Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.
We have not added a supplier for this profile. Missing products and coded listings are not filled with guesses.
Catalog checked 2026-10-04. Seller listings retain their stated intended use. Shops covered: BioLongevity Labs, BioLongevity Supplements, American Peptides, PSPeptides. This is not a market-wide comparison. Affiliate participation does not determine evidence or editorial coverage.
Questions worth asking
- Is MGF peptide evidence interchangeable with PEG-MGF or IGF-1 evidence?
- What material, population, and route were actually studied?
- Negative replication challenges broad muscle-regeneration claims. It does not prove that every splice product or future preparation lacks activity in all settings.
- What adverse effects, uncertainty, and conflicts of interest does the original source report?
Frequently asked questions
Is MGF peptide evidence interchangeable with PEG-MGF or IGF-1 evidence?
No. A terminal fragment, a full-length growth factor, and a PEG conjugate are different preparations. The negative fragment findings should remain visible.
Does the publication verify a supplier’s product?
No. The tested material and a commercial listing need separate identity and batch checks. A research-use disclaimer does not establish clinical suitability.
References & editorial record
Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation. Video notes specify which excerpts were reviewed; no full transcripts are published.